Aralez Pharmaceuticals (ARZ) Trading Down 5.5%
Aralez Pharmaceuticals Inc (TSE:ARZ)’s share price traded down 5.5% during mid-day trading on Wednesday . The stock traded as low as C$1.82 and last traded at C$1.92. 8,579 shares were traded during trading, a decline of 80% from the average session volume of 42,235 shares. The stock had previously closed at C$1.82.
ILLEGAL ACTIVITY NOTICE: “Aralez Pharmaceuticals (ARZ) Trading Down 5.5%” was reported by Daily Political and is the sole property of of Daily Political. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be read at https://www.dailypolitical.com/2017/12/15/aralez-pharmaceuticals-arz-trading-down-5-5.html.
Aralez Pharmaceuticals Company Profile
Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.
Receive News & Ratings for Aralez Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.